Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Solazyme Inc Reaffirms FY 2013 Revenue Guidance-Conference Call


Wednesday, 8 May 2013 04:30pm EDT 

Solazyme Inc announced that it continue to expect overall revenue growth of approximately 25% in fiscal 2013. The Company reported revenue of $44.11 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $54.20 million for fiscal 2013. 

Company Quote

9.28
0.24 +2.65%
29 Aug 2014